Stada buyout prescription finally shows results
Bain Capital and Cinven's €5.3bn buyout of German pharmaceuticals maker Stada went through this week, the firm announced on Friday, after a tense build up to Wednesday's midnight deadline, with the 63% shareholder acceptance threshold only just being reached.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: